002907 華森製藥
按盤價 
13.660 -0.470 (-3.326%)
13.660 -0.470 (-3.326%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.554 | 2.026 | 6.842 | 7.499 | 10.580 |
| 總資產報酬率 ROA (%) | 3.964 | 1.759 | 5.409 | 5.255 | 7.097 |
| 投入資產回報率 ROIC (%) | 4.537 | 2.017 | 6.269 | 6.154 | 8.400 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.693 | 54.978 | 59.335 | 52.735 | 48.066 |
| 營業利潤率 (%) | 14.499 | 6.626 | 13.860 | 12.210 | 15.574 |
| 息稅前利潤/營業總收入 (%) | 12.875 | 4.916 | 14.161 | 12.441 | 16.307 |
| 淨利潤/營業總收入 (%) | 12.142 | 4.728 | 12.532 | 10.847 | 13.506 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.128 | 84.081 | 91.697 | 90.159 | 74.389 |
| 價值變動淨收益/利潤總額(%) | -3.384 | -10.910 | -2.407 | -1.283 | 3.976 |
| 營業外收支淨額/利潤總額(%) | -0.431 | -7.071 | -0.544 | 0.104 | -0.284 | 償債能力分析 |
| 流動比率 (X) | 4.886 | 4.742 | 4.528 | 4.320 | 3.475 |
| 速動比率 (X) | 4.166 | 3.938 | 3.985 | 3.704 | 3.012 |
| 資產負債率 (%) | 13.309 | 12.613 | 13.729 | 28.539 | 31.346 |
| 帶息債務/全部投入資本 (%) | -2.456 | -2.368 | -2.329 | 13.681 | -- |
| 股東權益/帶息債務 (%) | -4,056.559 | -4,206.132 | -4,275.219 | 608.029 | 512.365 |
| 股東權益/負債合計 (%) | 651.346 | 692.802 | 628.379 | 250.398 | 219.021 |
| 利息保障倍數 (X) | -8.244 | -3.865 | 37.741 | 57.040 | 20.990 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 84.049 | 100.525 | 87.211 | 70.350 | 0.000 |
| 存貨周轉天數 (天) | 156.359 | 154.033 | 136.536 | 110.723 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 25/03/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
